Cargando…

CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy

Chemokines and their receptors participate in many biological processes, including the modulation of neuroimmune interactions. Approximately fifty chemokines are distinguished in humans, which are classified into four subfamilies based on the N-terminal conserved cysteine motifs: CXC, CC, C, and CX3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bogacka, Joanna, Pawlik, Katarzyna, Ciapała, Katarzyna, Ciechanowska, Agata, Mika, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779674/ https://www.ncbi.nlm.nih.gov/pubmed/36555280 http://dx.doi.org/10.3390/ijms232415638

Ejemplares similares

Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain
por: Pawlik, Katarzyna, et al.
Publicado: (2021)

Pharmacological Evidence of the Important Roles of CCR1 and CCR3 and Their Endogenous Ligands CCL2/7/8 in Hypersensitivity Based on a Murine Model of Neuropathic Pain
por: Pawlik, Katarzyna, et al.
Publicado: (2022)

Pharmacological Modulation of the MIP-1 Family and Their Receptors Reduces Neuropathic Pain Symptoms and Influences Morphine Analgesia: Evidence from a Mouse Model
por: Ciechanowska, Agata, et al.
Publicado: (2023)

CCR4 Antagonist (C021) Administration Diminishes Hypersensitivity and Enhances the Analgesic Potency of Morphine and Buprenorphine in a Mouse Model of Neuropathic Pain
por: Bogacka, Joanna, et al.
Publicado: (2020)

Analgesic Effects of Fisetin, Peimine, Astaxanthin, Artemisinin, Bardoxolone Methyl and 740 Y-P and Their Influence on Opioid Analgesia in a Mouse Model of Neuropathic Pain
por: Ciapała, Katarzyna, et al.
Publicado: (2023)

Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy
por: Kwiatkowski, Klaudia, et al.
Publicado: (2020)

New insights into the analgesic properties of the XCL1/XCR1 and XCL1/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies
por: Ciechanowska, Agata, et al.
Publicado: (2022)

Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4)
por: Wang, Ying, et al.
Publicado: (2006)

Dataset of (±)-NBI-74330 (CXCR3 antagonist) influence on chemokines under neuropathic pain
por: Piotrowska, Anna, et al.
Publicado: (2018)

Comparison of the Effects of Chemokine Receptors CXCR2 and CXCR3 Pharmacological Modulation in Neuropathic Pain Model—In Vivo and In Vitro Study
por: Piotrowska, Anna, et al.
Publicado: (2021)

Initiators of Classical and Lectin Complement Pathways Are Differently Engaged after Traumatic Brain Injury—Time-Dependent Changes in the Cortex, Striatum, Thalamus and Hippocampus in a Mouse Model
por: Ciechanowska, Agata, et al.
Publicado: (2020)

CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed Skin
por: Reiss, Yvonne, et al.
Publicado: (2001)

Traumatic brain injury in mice induces changes in the expression of the XCL1/XCR1 and XCL1/ITGA9 axes
por: Ciechanowska, Agata, et al.
Publicado: (2020)

Targeting Members of the Chemokine Family as a Novel Approach to Treating Neuropathic Pain
por: Pawlik, Katarzyna, et al.
Publicado: (2023)

Mirogabalin Decreases Pain-like Behaviours and Improves Opioid and Ketamine Antinociception in a Mouse Model of Neuropathic Pain
por: Zajączkowska, Renata, et al.
Publicado: (2022)

CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
por: Korbecki, Jan, et al.
Publicado: (2020)

Mirogabalin Decreases Pain-like Behaviors by Inhibiting the Microglial/Macrophage Activation, p38MAPK Signaling, and Pronociceptive CCL2 and CCL5 Release in a Mouse Model of Neuropathic Pain
por: Zajączkowska, Renata, et al.
Publicado: (2023)

Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10
por: Lim, Herman D., et al.
Publicado: (2021)

CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4
por: Korbecki, Jan, et al.
Publicado: (2020)

Natural Proteolytic Processing of Hemofiltrate Cc Chemokine 1 Generates a Potent Cc Chemokine Receptor (Ccr)1 and Ccr5 Agonist with Anti-HIV Properties
por: Detheux, Michel, et al.
Publicado: (2000)

In vitro pharmacoregulation of CC chemokine ligand 5 and its receptor CCR5 in diffuse lung diseases.
por: Sekerova, Veronika, et al.
Publicado: (2003)

Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor–A Literature Review
por: Korbecki, Jan, et al.
Publicado: (2020)

Targeting chemokine receptors in disease – a case study of CCR4
por: Solari, Roberto, et al.
Publicado: (2015)

Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the Cc Chemokine Receptor (Ccr2)
por: Izikson, Leonid, et al.
Publicado: (2000)

Cc Chemokine Receptor (Ccr)3/Eotaxin Is Followed by Ccr4/Monocyte-Derived Chemokine in Mediating Pulmonary T Helper Lymphocyte Type 2 Recruitment after Serial Antigen Challenge in Vivo
por: Lloyd, Clare M., et al.
Publicado: (2000)

Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-Chemokines
por: Hjortø, Gertrud M., et al.
Publicado: (2016)

A Study of CC-Chemokine Receptor 5 (CCR5) Polymorphism on the Outcome of HCV Therapy in Egyptian Patients
por: Omran, Moataza H, et al.
Publicado: (2013)

The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives
por: Ciapała, Katarzyna, et al.
Publicado: (2021)

Identification of CCR8: A Human Monocyte and Thymus Receptor for the CC Chemokine I-309
por: Tiffany, H. Lee, et al.
Publicado: (1997)

The role of CC-chemokine receptor 4 in murine polymicrobial sepsis
por: Maier, Stefan, et al.
Publicado: (2007)

Corrigendum: Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-Chemokines
por: Hjortø, Gertrud M., et al.
Publicado: (2017)

Induction of molecular remission by using anti-CC-chemokine receptor 4 (anti-CCR4) antibodies for adult T-cell leukemia: a risk of opportunistic infection after treatment with anti-CCR4 antibodies
por: Maeda, Yasuhiuro, et al.
Publicado: (2014)

Stimulation of oral fibroblast chemokine receptors identifies CCR3 and CCR4 as potential wound healing targets
por: Buskermolen, Jeroen K., et al.
Publicado: (2017)

Advances in Neuropathic Pain Research: Selected Intracellular Factors as Potential Targets for Multidirectional Analgesics
por: Ciapała, Katarzyna, et al.
Publicado: (2023)

Chemokine Receptor-Targeted Therapies: Special Case for CCR8
por: Moser, Bernhard
Publicado: (2022)

Role of the Chemokine Receptors CCR1, CCR2 and CCR4 in the Pathogenesis of Experimental Dengue Infection in Mice
por: Guabiraba, Rodrigo, et al.
Publicado: (2010)

Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury
por: Piotrowska, Anna, et al.
Publicado: (2019)

A Highly Selective Cc Chemokine Receptor (Ccr)8 Antagonist Encoded by the Poxvirus Molluscum Contagiosum
por: Lüttichau, Hans R., et al.
Publicado: (2000)

CC‐chemokine receptor 7 (CCR7) deficiency alters adipose tissue leukocyte populations in mice
por: Orr, Jeb S., et al.
Publicado: (2016)

CC chemokines and receptors in osteoarthritis: new insights and potential targets
por: Zhang, Yuchen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1hd2llm0rvfvfp7jsa1fun4ht0